Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.420
+0.140 (6.14%)
Mar 4, 2026, 2:40 PM EST - Market open
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $434.75 million as of March 4, 2026. Its market cap has increased by 560.16% in one year.
Market Cap
434.75M
Enterprise Value
345.16M
1-Year Change
560.16%
Ranking
Category
Stock Price
$2.42
Market Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $434.75M, a decrease of -58.63%. That is a compound annual growth rate of -17.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 409.60M | 371.56% |
| Dec 31, 2025 | 86.86M | 1.14% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
| Jun 18, 2021 | 1.05B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entrada Therapeutics | 420.48M |
| Anavex Life Sciences | 419.80M |
| DiaMedica Therapeutics | 416.84M |
| Upstream Bio | 416.10M |
| Armata Pharmaceuticals | 415.77M |
| Ginkgo Bioworks Holdings | 410.36M |
| PureTech Health | 401.96M |
| Immutep | 400.69M |